Samsung Medical Center
Ewing's sarcoma treatment cost in South Korea typically includes essential diagnostics like a PET/CT scan from Price on request to Price on request . Primary treatment involving sarcoma surgery ranges from AUD $10,675 to AUD $17,418. Total expenses depend on the cancer stage and required chemotherapy sessions. Patients generally save around 30–50% compared to private healthcare costs in Australia. Seoul is the primary hub for this specialised care.
Typical Ewing's Sarcoma Treatment Costs in South Korea
Bookimed Expert Insight: For complex cases, patients benefit from hospitals using integrated digital systems to reduce errors. Seoul National University Bundang Hospital uses the BESTcare system to improve patient safety. Those needing advanced surgical precision should consider centres with robotic capabilities. Samsung Medical Center utilises Da Vinci robots and AI-driven imaging for complex oncological procedures. Larger multidisciplinary centres like Asan Medical Center handle massive patient volumes, ensuring surgeons manage rare sarcomas routinely.
| Republic of Korea | Thailand | Turkey | |
| Sarcoma surgery | from AUD $10,675 | from AUD $42,140 | from AUD $14,047 |
| Chemotherapy for breast cancer | from AUD $26,969 | from AUD $4,214 | from AUD $1,686 |
| Radiation therapy for colorectal cancer | - | from AUD $7,726 | from AUD $9,833 |
| Radiation Therapy for Sarcomas | - | from AUD $9,833 | from AUD $4,565 |
| Complex treatment of Ewing's sarcoma | - | from AUD $49,163 | from AUD $42,140 |
No hidden fees – just official clinic prices. Pay at the clinic for Ewing's sarcoma treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Ewing's sarcoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Ewing's sarcoma treatment journey.
South Korean hospitals treat Ewing's sarcoma using a multimodal approach. This combines intensive systemic chemotherapy with surgery or radiation. Major Seoul centres perform complex limb-salvage operations. They use imaging to secure clear margins while preserving function. Treatment typically lasts 6 to 9 months.
Bookimed Expert Insight: Samsung Medical Center serves over 2,000,000 patients annually and houses Asia's largest cancer centre. This high volume allows for 17 disease-specific departments. Such specialisation helps South Korean teams manage rare sarcomas with high precision. Asan Medical Center also provides personal coordinators. This supports Australian patients through complex surgical and recovery phases.
Patient Consensus: Patients note that treatment involves months of therapy even after successful surgery. Clear surgical margins are essential for long-term recovery in South Korea. Teams often prioritise reconstruction and limb preservation over amputation when the tumour location allows.
Samsung Medical Center and Asan Medical Center are leading choices for Ewing's sarcoma treatment. They are located in South Korea. These Seoul-based hubs use proton beam therapy and multidisciplinary teams. They hold Korean Institute for Healthcare Accreditation (KOIHA) and Newsweek rankings. This means they meet high standards for complex bone cancer cases.
Bookimed Expert Insight: While major Seoul hospitals offer similar clinical quality, international patient infrastructure varies. Asan Medical Center stands out by assigning a personal coordinator to every international patient. This support is vital for Ewing's sarcoma, because treatment often involves complex, multi-stage protocols. These require constant communication between oncology and orthopaedic teams.
Patient Consensus: Patients note that Seoul's major university hospitals provide elite cancer care. However, they can be very busy. Those travelling to South Korea suggest choosing centres with dedicated international clinics. These handle appointments and English translation more efficiently.
The 5-year overall survival rate for Ewing's sarcoma in South Korea is 52% across all ages. Paediatric patients under 15 show a 75% survival rate. Major Seoul hospitals use multidisciplinary teams. They also use technologies like proton beam therapy and Gamma Knife for these complex bone tumours.
Bookimed Expert Insight: Samsung Medical Center serves over 2 million outpatients annually. It also operates Asia’s largest cancer centre. Korean specialists see rare Ewing's cases more frequently than many Western regional centres. This is because of the massive patient volume. Their use of real-time digital image sharing between oncologists and surgeons helps speed up critical treatment decisions.
Patient Consensus: Patients value the speed of diagnosis in Seoul, noting that PET-CT and biopsies happen quickly. Many highlight the helpfulness of personal coordinators at major hospitals. These coordinators assist with medical translations during oncologist appointments.
South Korea offers radiation therapy for Ewing's sarcoma through specialised oncology centres in Seoul. Facilities such as Samsung Medical Center and Soon Chun Hyang University Hospital provide proton beam therapy and Tomotherapy. These precise techniques target tumours while sparing healthy tissues and surrounding organs.
Bookimed Expert Insight: South Korea's oncology landscape is defined by massive patient volumes and digital integration. Samsung Medical Center treats over 2,000,000 outpatients annually and partners with the Mayo Clinic. For Ewing's sarcoma patients, this means access to centres with 17 disease-specific departments. This scale allows specialists to manage thousands of complex cases. They do so with high precision and safety.
Patient Consensus: Patients find radiation manageable but tiring. They emphasise that proton therapy is particularly helpful for tumours near critical organs. In South Korea, coordinating care is simplified by dedicated international units. These units assist with travel and billing.
South Korean medical centres provide autologous stem cell transplantation. This treats relapsed or refractory Ewing's sarcoma. This procedure usually follows high-dose chemotherapy to help the bone marrow recover. Specialists at Samsung Medical Center or Asan Medical Center evaluate cases based on chemo-sensitivity.
Bookimed Expert Insight: Many centres offer stem cell transplants. However, for Ewing's sarcoma relapse, expertise is concentrated in Seoul's multi-disciplinary centres. Asan Medical Center performs over 65,000 surgeries annually. It maintains some of South Korea's highest success rates for complex procedures. This high volume often leads to better results. This applies especially to rare paediatric and adolescent bone tumours.
Patient Consensus: Patients find that South Korean hospitals offer more personalised protocols. This goes beyond a simple yes or no answer. They suggest confirming if the transplant is routine or trial-based. Eligibility often depends on how well the relapse responds to initial salvage chemotherapy.
South Korean oncology centres treat Ewing's sarcoma using intensive multi-agent chemotherapy. Primary protocols typically alternate between vincristine, doxorubicin, and cyclophosphamide (VDC) and ifosfamide and etoposide (IE). Major Seoul hospitals like Samsung Medical Centre follow these international standards. This allows them to treat both localised and metastatic cases efficiently.
Bookimed Expert Insight: Samsung Medical Centre and Asan Medical Centre perform over 45,000 and 65,000 annual surgeries respectively. Their high patient volumes mean oncologists there handle rare Ewing's cases more frequently. They see more of these cases than doctors at smaller regional hospitals. This experience often leads to more precise side-effect management. This is especially true during long 14-cycle chemotherapy protocols.
Patient Consensus: Patients note that doxorubicin and ifosfamide phases cause the most significant side effects. They recommend discussing anti-nausea plans early. This is because reactions differ between drug cycles in South Korea.
International patients can receive Ewing's sarcoma treatment in South Korea. Major Seoul-based medical centres provide comprehensive surgery, chemotherapy, and proton beam therapy. These clinics hold JCI or KOIHA accreditations. They often manage over 45,000 surgeries yearly with specialised oncology departments.
Bookimed Expert Insight: While many oncology centres exist, Samsung Medical Center stands out. It is Asia's largest cancer centre, with 17 disease-specific departments. This clinical depth means patients with rare Ewing's sarcoma access teams who manage high volumes of complex cases. This level of specialisation is rarely found outside major global hubs.
Patient Consensus: Patients recommend contacting Seoul university hospitals early and sending pathology slides before travelling. Reliable translation support and help with foreign insurance billing make the process smoother in South Korea.